eIF5A1 Inhibitors are a specialized class of chemical compounds that target and inhibit the activity of eukaryotic initiation factor 5A1 (eIF5A1), a highly conserved protein involved in the regulation of translation. eIF5A1 is unique because it is the only known protein to undergo post-translational modification by hypusination, a process that is crucial for its function in promoting the synthesis of specific proteins, particularly those involved in cell proliferation, differentiation, and stress responses. By inhibiting eIF5A1, researchers can study the detailed mechanisms of translation elongation and the role of hypusinated eIF5A1 in various cellular processes, including the synthesis of proteins that are otherwise challenging to produce or regulate within the cell.
The inhibition of eIF5A1 is particularly valuable for exploring its involvement in the regulation of proteins with proline-rich sequences, which are known to be critical for the control of cell cycle progression and apoptosis. eIF5A1 Inhibitors provide a powerful tool for dissecting the molecular pathways that rely on these specific proteins, allowing scientists to gain insights into how cells regulate essential functions like growth, division, and response to environmental stressors. Furthermore, these inhibitors offer a way to study the broader impact of translation control on cellular homeostasis and the maintenance of protein quality. By modulating eIF5A1 activity, researchers can explore how the balance of protein synthesis and degradation is maintained in the cell and how disruptions to this balance can lead to various cellular outcomes. Overall, eIF5A1 Inhibitors serve as a critical resource for advancing our understanding of the complex network of interactions that govern translation and protein synthesis in eukaryotic cells.
関連項目
Items 1 to 10 of 18 total
展示:
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
Salubrinal | 405060-95-9 | sc-202332 sc-202332A | 1 mg 5 mg | $33.00 $102.00 | 87 | |
Salubrinal抑制eIF2α去磷酸化,延长磷酸化时间,从而减少翻译起始。 | ||||||
Guanabenz HCl | 23113-43-1 | sc-507500 | 100 mg | $241.00 | ||
Guanabenz通过激活eIF2α磷酸酶PP1来减少eIF2α的磷酸化,从而允许翻译正常进行。 | ||||||
GSK 2606414 | 1337531-36-8 | sc-490182 sc-490182A | 5 mg 25 mg | $160.00 $561.00 | ||
GSK2606414抑制PERK的活性,后者是一种磷酸化eIF2α的激酶,从而降低eIF2α的磷酸化水平。 | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $76.00 $216.00 | 101 | |
顺铂通过造成DNA损伤、触发综合应激反应和eIF2α磷酸化,间接影响eIF2α。 | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin诱导ER应激,激活PERK并导致eIF2α磷酸化,从而抑制蛋白质合成。 | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $32.00 $170.00 $385.00 | 63 | |
依托泊苷导致DNA损伤,从而可能引发细胞应激反应,从RNAi途径转移细胞资源,从而下调eIF2C2。 | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
5-氟尿嘧啶作为一种嘧啶类似物,可能会破坏核苷酸代谢。这种破坏会通过阻碍RNA合成间接影响RNAi组件,导致eIF2C2水平下降。 | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
硼替佐米抑制蛋白酶体,影响蛋白质的更新。这可能会破坏细胞蛋白质的平衡,从而降低eIF2C2的稳定性或合成。 | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
放线菌素D通过插入DNA来阻碍RNA合成。这会导致RNA衍生过程的普遍下调,其中可能包括eIF2C2水平的降低。 | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
环己酰胺通过抑制蛋白质合成,可能会阻止新的eIF2C2分子的产生,导致eIF2C2的净减少,因为现有蛋白质会降解。 |